Emtricitabine and Tenofovir Alafenamide are used in the treatment of HIV infection.
How Emtricitabine and Tenofovir Alafenamide Work Emtricitabine and tenofovir alafenamide are a combination of two medications that belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Emtricitabine disrupts the viral life cycle by inhibiting a key enzyme called HIV-1 reverse transcriptase. Tenofovir alafenamide is converted to tenofovir diphosphate, which is incorporated into viral DNA, leading to the inhibition of HIV replication.
Common side effects of Emtricitabine and Tenofovir Alafenamide include nausea, diarrhea, headache, depression, rash, dizziness, fatigue, vomiting, insomnia (difficulty sleeping), weakness, allergic reactions, abnormal dreams, decreased phosphate levels in the blood, decreased white blood cell count (neutrophils), increased triglyceride levels in the blood, abdominal pain, weight loss, upper respiratory tract infections, increased transaminase levels in the blood, increased glucose levels in the blood, elevated serum amylase levels, increased lipase levels in the blood, and elevated creatine kinase levels.
Bictegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg

₹4,800

₹3,690
MRP ₹4,500
Bictegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg

₹3,690
MRP ₹4,500
Dolutegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg

₹13,165.5

₹3,481.6
MRP ₹4,521.5
Dolutegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg

₹3,481.6
MRP ₹4,521.5
Emtricitabine 200mg + Tenofovir Alafenamide 25mg

₹1,859.1

₹1,399
MRP ₹1,943
Emtricitabine 200mg + Tenofovir Alafenamide 25mg

₹1,399
MRP ₹1,943